| __timestamp | Ionis Pharmaceuticals, Inc. | PTC Therapeutics, Inc. |
|---|---|---|
| Wednesday, January 1, 2014 | 20140000 | 44820000 |
| Thursday, January 1, 2015 | 37173000 | 82080000 |
| Friday, January 1, 2016 | 48616000 | 97130000 |
| Sunday, January 1, 2017 | 108488000 | 121271000 |
| Monday, January 1, 2018 | 244622000 | 153548000 |
| Tuesday, January 1, 2019 | 287000000 | 202541000 |
| Wednesday, January 1, 2020 | 354000000 | 245164000 |
| Friday, January 1, 2021 | 186000000 | 285773000 |
| Saturday, January 1, 2022 | 151000000 | 325998000 |
| Sunday, January 1, 2023 | 232600000 | 332540000 |
| Monday, January 1, 2024 | 267474000 |
In the ever-evolving landscape of biotechnology, understanding the financial dynamics of industry leaders is crucial. Over the past decade, Ionis Pharmaceuticals and PTC Therapeutics have demonstrated distinct trends in their Selling, General, and Administrative (SG&A) expenses. From 2014 to 2023, Ionis Pharmaceuticals saw a staggering increase of over 1,000% in SG&A costs, peaking in 2020. This surge reflects their aggressive expansion and investment in administrative capabilities. Meanwhile, PTC Therapeutics experienced a more consistent growth trajectory, with a notable 640% rise in SG&A expenses by 2023. This steady increase underscores their strategic focus on sustainable growth. The data reveals a fascinating narrative of how these biotech titans allocate resources to maintain competitive edges. As the industry continues to innovate, monitoring these financial strategies offers valuable insights into future market movements.
Comparing SG&A Expenses: AstraZeneca PLC vs PTC Therapeutics, Inc. Trends and Insights
SG&A Efficiency Analysis: Comparing Zoetis Inc. and PTC Therapeutics, Inc.
Cost Management Insights: SG&A Expenses for Alnylam Pharmaceuticals, Inc. and Ionis Pharmaceuticals, Inc.
Breaking Down SG&A Expenses: Viatris Inc. vs PTC Therapeutics, Inc.
Comparing SG&A Expenses: Walgreens Boots Alliance, Inc. vs Ionis Pharmaceuticals, Inc. Trends and Insights
SG&A Efficiency Analysis: Comparing Ascendis Pharma A/S and PTC Therapeutics, Inc.
Ionis Pharmaceuticals, Inc. vs Apellis Pharmaceuticals, Inc.: SG&A Expense Trends
Cost Management Insights: SG&A Expenses for Ionis Pharmaceuticals, Inc. and Travere Therapeutics, Inc.
Selling, General, and Administrative Costs: Ionis Pharmaceuticals, Inc. vs Xencor, Inc.
SG&A Efficiency Analysis: Comparing PTC Therapeutics, Inc. and Amicus Therapeutics, Inc.
Comparing SG&A Expenses: PTC Therapeutics, Inc. vs Taro Pharmaceutical Industries Ltd. Trends and Insights
Breaking Down SG&A Expenses: PTC Therapeutics, Inc. vs MiMedx Group, Inc.